After recapturing its 200 DMA back in March and subsequently vaulting from a 3 to 4 - handle, ZIOPHARM ONCOLOGY INC - NASDAQ:ZIOP has found itself in a sideways drift and appears to be building a base these past couple of months as we can observe from the Daily chart above. With the stock trading above all of its important moving averages 20/50/200 DMA's, ZIOP...
A break below rising diagonal (wedge) confirms a sell signal for Ziopharm Oncology Inc. 200 moving average and 50 moving average of the 1 hour timeframe are also included with both indicating and supporting bearish bias. Minimum expectation for price action is the origin of the wedge.
Perfect setup forming for a good short opp from $5.00 - $3.25
Good entry for ZIOP because: (1) Zacks Rank = #2 (buy (short-term: next 1-3 months) (2) Zacks ABR (5 brokers last week) = 2.20 (buy) (3) Zacks Average Target Price = $12.50 (almost triple current price at $4.30) (4) Broke out of descending trendline (5) Risk-reward ratio = 1:1+ Research and trade carefully. Peace
In and out of this little fella last month, back into it this, as implied volatility in the underlying remains high, and I don't have to do all that much due diligence, since I already know what's in the pipeline, etc. Metrics: Bought Shares at 5.27 Sold Oct 21st 6 call Whole Package: 4.82 db Max Profit: $118 (if called away at 6)
Here's my "short list" for covered call candidates for next week generated by looking at Barcharts.com high volatility stock options list and the Dough grid: WLL buy shares at 7.66; sell Sept 16th 8 call; 7.10 debit; $90 max profit (12.7% ROC) CC buy shares at 11.45; sell Sept 16th 12 call; 10.78 debit; $122 max profit (10.6% ROC) LC buy shares at 5.40; sell Oct...
Bought shares of ZIOP at market open at 4.90, selling the Aug 19th 5 short call against, immediately reducing my cost basis in my shares to 4.20, so my max profit is $80/contract if called away at 5. Thanks to TurboTech for spotting this high implied volatility premium selling gem!
Shares of DSKX continues to rally from last week after they held a conference call to discuss the recently announced agreement to acquire Radiancy, Inc., a leading developer of consumer medical devices and the Neova® dermatological products. It appears investors are beginning to notice the financial value this new deal brings and the future outlook of the company,...
ZIOP has completed an alternate bat pattern. The pattern completion is confluent with a .886 fib level on a higher TF structure low to structure high. A trendline was broken and retested on 12/22, indication of possible upcoming bullish movement at the PRZ. A second trendline was broken today, which may be an opportunity to catch the breakout toward .382CD. ...
NWS candle today. Bullish volume on hourly and daily. EMA's are bullish.